Table 5.
Details of severe (> grade 2) complications
| No. | Toxicity | Grade | Onset (months) | No. of ICRT | Risk |
|---|---|---|---|---|---|
| 1 | Intestinal obstruction | 3 | 4 | 4 | None |
| 2 | Bloody stool | 3 | 8 | 4 | Steroid for rheumatoid arthritis |
| 3 | Bloody stool | 3 | 59 | 4 | None |
| 4 | Bloody stool | 3 | 8 | 4 | None |
| 5 | Bloody stool | 3 | 10 | 4 | None |
| 6 | Bloody stool | 3 | 9 | 5 | None |
| 7 | Bloody stool | 3 | 14 | 4 + α | Re-ICBT for local recurrence |
| 8 | Bloody stool | 3 | 10 | 4 | None |
| 9 | Small-intestinal perforation | 4 | 7 | 5 | FEC regimen for breast cancer |
| 10 | Small-intestinal perforation | 4 | 16 | 4 | Diabetes mellitus (type 1) |
| 11 | Small-intestinal perforation | 4 | 9 | 4 | Severe constipation |
| 12 | Cystitis | 4 | 20 | 4 | Severe constipation |
FEC regimen – 5-fluorouracil/epirubicin/cyclophosphamide